| An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD) (NCT07750990) | Shionogi | 2026-08-31 |
| A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease (NCT07743580) | Shionogi | 2026-08-06 |
| Study of Secutrelvir in Participants With COVID-19 (NCT07746544) | Shionogi | 2026-07-20 |
| Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD) (NCT07123155) | Shionogi | 2025-10-30 |
| A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls (NCT07217886) | Shionogi | 2025-10-16 |
| Phase 1 Study of BPN14770 in Participants With Hepatic Impairment and Healthy Controls (NCT07018492) | Shionogi | 2025-08-30 |
| Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls (NCT07012005) | Shionogi | 2025-08-25 |
| Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants (NCT07093580) | Shionogi | 2025-07-29 |
| A Study to Assess the Effects of BPN14770 on Rosuvastatin (NCT07011992) | Shionogi | 2025-07-18 |
| A Study of S-892216 in Participants With COVID-19 (NCT06928051) | Shionogi | 2025-06-06 |
| Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) (NCT06717438) | Shionogi | 2025-05-13 |
| Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea (NCT06776432) | Shionogi | 2025-04-02 |
| A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants (NCT06751017) | Shionogi | 2024-12-17 |
| A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants (NCT06746051) | Shionogi | 2024-12-09 |
| A Study of S-740792 in Healthy Adult Study Participants (NCT06724978) | Shionogi | 2024-11-21 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants (NCT06086626) | Shionogi | 2024-03-14 |
| A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants (NCT06270511) | Shionogi | 2024-03-13 |
| Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants (NCT06106334) | Shionogi | 2023-11-15 |
| A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke (NCT05953480) | Shionogi | 2023-07-14 |
| Safety and Efficacy Study of S-309309 in Obese Adults (NCT05925114) | Shionogi | 2023-06-21 |
| Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection (NCT05897541) | Shionogi | 2023-06-09 |
| Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids (NCT05588323) | Shionogi | 2023-01-04 |
| Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS (NCT05568615) | Shionogi | 2022-10-26 |
| A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants (NCT05409911) | Shionogi | 2022-09-13 |
| A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants (NCT05363215) | Shionogi | 2022-08-10 |
| A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (NCT05305547) | Shionogi | 2022-08-03 |
| Use of Cefiderocol in the Management of Gram-Negative Infections (NCT05789199) | Shionogi | 2022-07-31 |
| S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors (NCT05101070) | Shionogi | 2022-05-30 |
| A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants (NCT05395104) | Shionogi | 2022-05-24 |
| A Study of S-268019 for the Prevention of COVID-19 (NCT05212948) | Shionogi | 2021-12-25 |
| Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube (NCT04776135) | Shionogi | 2021-02-26 |
| Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS (NCT04569084) | Shionogi | 2020-11-13 |
| Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device (NCT04631354) | Shionogi | 2020-11-09 |
| A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection (NCT04355169) | Shionogi | 2020-11-06 |
| Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT04577404) | Shionogi | 2020-10-29 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants (NCT04335539) | Shionogi | 2020-08-21 |
| Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments (NCT04607707) | Shionogi | 2020-07-07 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants (NCT04215991) | Shionogi | 2020-02-19 |
| Evaluation of S-600918 in Adults With Refractory Chronic Cough (NCT04110054) | Shionogi | 2020-02-13 |
| Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy (NCT04254913) | Shionogi | 2020-01-24 |
| Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) (NCT04259255) | Shionogi | 2019-10-21 |
| Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults (NCT04147715) | Shionogi | 2019-10-09 |
| First-in-human Study of S-588210 (S-488210+S-488211) (NCT04316689) | Shionogi | 2019-07-30 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) (NCT05342597) | Shionogi | 2019-06-10 |
| Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (NCT04176224) | Shionogi | 2019-04-17 |
| Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects (NCT04493281) | Shionogi | 2019-03-22 |
| Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia (NCT03862040) | Shionogi | 2019-02-20 |
| PK Study in Subjects With Severe Hepatic Impairment (NCT03664544) | Shionogi | 2018-11-06 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) (NCT04481789) | Shionogi | 2018-10-17 |
| A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects (NCT04029090) | Shionogi | 2018-09-18 |
| Study of Oral Edaravone in Healthy Adult Males (NCT04481750) | Shionogi | 2018-03-20 |
| A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder (NCT03395353) | Shionogi | 2018-01-29 |
| A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder (NCT03315793) | Shionogi | 2017-12-04 |
| Dose Finding Study of MCI-186 in Acute Ischemic Stroke (NCT03346538) | Shionogi | 2017-11-17 |
| Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens (NCT03032380) | Shionogi | 2017-10-24 |